Skip to main content
. 2024 Feb 10;15(4):1101–1110. doi: 10.1007/s41999-024-00937-8

Table 3.

Prevalence ratio (95% confidence interval) for malfunction status of IADL: determined by Poisson regression analysis

Variables n Prevalence of IADL disability, n (%) Crude model Model 1 Model 2
PR (95% CI) PR (95% CI) PR (95% CI)
Diabetic nephropathy 88 15 (17.0) 1.55 (0.77–3.13) 1.77 (0.92–3.42) 1.78 (0.93–3.42)
Physical frailty 49 11 (22.4) 2.09 (1.04–4.20) 0.88 (0.47–1.67) 0.78 (0.42–1.45)
Depression 18 7 (38.9) 3.44* (1.69–7.01) 2.47* (1.30–4.71) 1.90 (0.89–4.05)
Cognitive decline 30 11 (36.7) 3.85* (1.99–7.47) 1.31 (0.60–2.89) 1.41 (0.65–3.05)
Low muscle strength 55 16 (29.1) 4.55* (2.07–9.99) 2.85* (1.30–6.27) 2.56 (1.15–5.68)

Model 1: adjusted for propensity score (including age, gender, use of insulin, HbA1c, BMI, self-rated health, smoking status, physical activity level, academic history, economic condition, living status, other comorbidities). Model 2: Model 1 + score of Lubben Social Network Scale-6

IADL instrumental activities of daily living, PR prevalence ratio, CI confidence interval

*P < 0.01 (Bonferroni correction was used to adjusted the level of significance from 0.05 to 0.05/5 = 0.01)